Furthermore, ADAR1 depletion or the use of ADAR1 small molecule inhibitors presents a potential therapeutic avenue for cancer patients, augmenting cellular sensitivity to immune checkpoint blockade.105, 153. This evidence concerns the gene ADAR and cancer.